Joshua Dennerlein
Stock Analyst at B of A Securities
(2.17)
# 1,497
Out of 4,667 analysts
87
Total ratings
43.14%
Success rate
-5.06%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SUI Sun Communities | Downgrades: Underperform | $147 → $114 | $126.26 | -9.71% | 2 | Nov 12, 2024 | |
FVR FrontView REIT | Initiates: Buy | $22 | $18.36 | +19.83% | 1 | Oct 28, 2024 | |
GTY Getty Realty | Upgrades: Buy | $31 → $34 | $32.70 | +3.98% | 3 | Oct 21, 2024 | |
AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $27.66 | +12.08% | 2 | Sep 24, 2024 | |
NHI National Health Investors | Initiates: Buy | $92 | $77.14 | +19.26% | 1 | Sep 24, 2024 | |
ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $300.59 | +6.79% | 3 | Sep 24, 2024 | |
LINE Lineage | Initiates: Buy | $100 | $63.86 | +56.59% | 1 | Aug 19, 2024 | |
CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $120.56 | +21.93% | 4 | Aug 12, 2024 | |
MAA Mid-America Apartment Communities | Upgrades: Buy | $144 → $189 | $157.74 | +19.82% | 3 | Aug 12, 2024 | |
EPR EPR Properties | Downgrades: Underperform | $45 → $40 | $44.28 | -9.67% | 4 | May 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $21.43 | +16.66% | 2 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $39.88 | -22.27% | 11 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $64.11 | -17.33% | 9 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $10.98 | -45.36% | 1 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $44.34 | -25.58% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $15.98 | -6.13% | 2 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $56.88 | -8.58% | 1 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.39 | - | 4 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $56.59 | -4.58% | 4 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.26 | +87.79% | 9 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $12.74 | +111.93% | 1 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $22.81 | +46.87% | 5 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $33.56 | - | 4 | Aug 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $77.01 | +1.29% | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $43.92 | +7.01% | 2 | Jan 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $73 → $78 | $137.40 | -43.23% | 5 | Mar 30, 2021 |
Sun Communities
Nov 12, 2024
Downgrades: Underperform
Price Target: $147 → $114
Current: $126.26
Upside: -9.71%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $18.36
Upside: +19.83%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $32.70
Upside: +3.98%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $27.66
Upside: +12.08%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $77.14
Upside: +19.26%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $300.59
Upside: +6.79%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $63.86
Upside: +56.59%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $120.56
Upside: +21.93%
Mid-America Apartment Communities
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $157.74
Upside: +19.82%
EPR Properties
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $44.28
Upside: -9.67%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $21.43
Upside: +16.66%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $39.88
Upside: -22.27%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $64.11
Upside: -17.33%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $10.98
Upside: -45.36%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $44.34
Upside: -25.58%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $15.98
Upside: -6.13%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $56.88
Upside: -8.58%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $18.39
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $56.59
Upside: -4.58%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.26
Upside: +87.79%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $12.74
Upside: +111.93%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $22.81
Upside: +46.87%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $33.56
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $77.01
Upside: +1.29%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $43.92
Upside: +7.01%
Mar 30, 2021
Upgrades: Buy
Price Target: $73 → $78
Current: $137.40
Upside: -43.23%